Colon Cancer Services For Medical Specialties
-
based in USA
LiquidHALLMARK® is an ultrasensitive next-generation sequencing assay for genomic profiling of a patient’s unique cancer. By requiring only a single blood sample, LiquidHALLMARK provides important information for cancer care especially when tissue by invasive biopsy is insufficient or ...
-
Manufactured by CDx Diagnostics Inc.based in USA
Routine clinical use of CDx testing has already detected thousands of precancers and cancers that would otherwise have been missed in time for effective endoscopic treatment. CDx Diagnostics is looking to apply the WATS3D platform to prevent cancers of the bile duct, stomach, and ...
-
Manufactured by IMB Dx, Inc.based in SOUTH KOREA
The AlphaLiquid® platform is being widely applied in translational research to empower our understanding of tumor evolution, response to therapy and resistance mechanisms, as well as to provide insights on the clinical value of ctDNA analysis in precision ...
-
based in USA
Auspex Diagnostic’s colorectal cancer test is a revolutionary treatment planning tool that can help stage II and III colorectal cancer patients and doctors personalize the treatment to the individual patient’s genes. Since no two patients are the alike, it is crucial that patients learn as much as possible about their tumor to determine the most suitable treatment plan. The test ...
-
Manufactured by Alfa Scientific Designs, Incbased in USA
ALFA offers development services to include contract product development. technology transfer, and various technological offerings such as latex, lateral flow, and fluorescent methodologies. ALFA develops breakthrough designs produced to the highest quality standards and provides a complete solution for customer specific design, assay development, laboratory and clinical sample testing. ...
-
based in USA
Drive sales by demonstrating the exceptional antioxidant levels in your fresh foods, prepared foods, and beverage products. Antioxidant Superfood certification is a groundbreaking program reserved exclusively for foods and beverages that deliver the essential antioxidants consumers need every day to reap important health benefits. This unique certification, backed by the latest published research ...
-
Manufactured by Arthus Biosystems, LLCbased in USA
It has been shown that changes of intracellular levels of S-adenosylmethionine (SAM) are related to the well beings of cells and organisms. The fluctuation of SAM level is cause by imbalance between SAM synthesis and metabolic pathways (methylation, transsulfuration and aminiopropylation) or degradation. S-adenosylmethionine biosynthesis is strictly and solely dependent on the activity of ...
-
based in CANADA
While tissue samples are the standard for cancer molecular profiling, tissue can often be challenging to obtain. Surgical biopsy may be risky or impossible, the biopsy procedure may have resulted in insufficient or exhausted tissue, or the sample acquired resulted in poor quality DNA. Whatever the reason, plasma assays can provide a less invasive alternative or complement to tissue assays. Plasma ...
-
based in CANADA
Find It focuses on gene mutations that can be addressed by current FDA-approved therapies. Find It is more than an assay: it’s a complete solution. Canexia Health partners leverage our expert end-to-end support and proprietary technology as well as a focused panel that identifies therapeutic targets for patients, acquired drug resistance mutations, and mutations with prognostic and ...
-
Manufactured by Arthus Biosystems, LLCbased in USA
S-adenosylmethionine (SAM) is an important molecule in methionine cycle pathway and one carbon metabolism pathway that are implicated in many metabolic abnomalities found in humans. Methylation index is defined as the ratio of SAM and SAH, which is a better way to evaluate methylation status of humans and other organisms. The level of S-adenosylmethionine (SAM) fluctuates depending on age, ...
-
based in SWITZERLAND
Leading-edge therapies that leverage the microbiome promise to address a range of serious diseases that currently don’t have adequate solutions. Microbiome-based therapies are de-risked thanks to the established proof-of-concept with fecal matter transplant ...
-
Manufactured by BiomXbased in ISRAEL
Our colorectal cancer program utilizes engineered phage with various payloads (such as immunostimulatory payloads) that are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. The aim of payload delivery is to convert cold tumors to hot tumors with activated immune responses. ...
-
Manufactured by Lupin Limitedbased in INDIA
The NDDD team has developed a pipeline of highly differentiated and innovative new chemical entities in focused therapeutic areas of Oncology, Immunology and Metabolic ...
-
based in USA
Until now, cancer patients and caretakers in various stages often face the dilemma when deciding whether or not to receive chemotherapy as part of the treatment for two primary reasons – uncertainty of future cancer relapse and efficacy of chemotherapy. If the cancer has low likelihood of relapse, the patients could be wasting time and money on unnecessary treatment. On the other hand, if a ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you